ORC
CL icon

O'Rourke & Company’s Colgate-Palmolive CL Stock Holding History

O'Rourke & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
3,077
-157
-5% -$13.7K 0.1% 144
2026
Q1 		$276K Buy
3,234
+397
+14% +$35.4K 0.11% 142
2025
Q4 		$224K Sell
2,837
-448
-14% -$35.1K 0.09% 151
2025
Q3 		$263K Sell
3,285
-200
-6% -$17.1K 0.11% 145
2025
Q2 		$317K Hold
3,485
– – 0.15% 127
2025
Q1 		$327K Sell
3,485
-160
-4% -$14.3K 0.16% 121
2024
Q4 		$331K Sell
3,645
-460
-11% -$43.9K 0.16% 122
2024
Q3 		$426K Buy
4,105
+260
+7% +$26.5K 0.21% 94
2024
Q2 		$373K Hold
3,845
– – 0.21% 95
2024
Q1 		$346K Hold
3,845
– – 0.2% 105
2023
Q4 		$306K Hold
3,845
– – 0.2% 103
2023
Q3 		$273K Sell
3,845
-100
-3% -$7.48K 0.2% 101
2023
Q2 		$304K Sell
3,945
-500
-11% -$38.7K 0.21% 101
2023
Q1 		$334K Hold
4,445
– – 0.25% 89
2022
Q4 		$350K Hold
4,445
– – 0.28% 85
2022
Q3 		$312K Buy
4,445
+300
+7% +$23.5K 0.27% 83
2022
Q2 		$332K Sell
4,145
-260
-6% -$20.3K 0.28% 80
2022
Q1 		$334K Buy
4,405
+260
+6% +$20.6K 0.23% 90
2021
Q4 		$354K Buy
+4,145
New +$324K 0.24% 83

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

O'Rourke & Company's CL Position: Q2 2026 in Review

O'Rourke & Company reduced its Colgate-Palmolive (CL) stake by 4.9% in Q2 2026, selling an estimated $13.7K and leaving 3,077 shares worth $282K. The position accounts for 0.1% of the portfolio, ranked #144.

O'Rourke & Company first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $426K in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • O'Rourke & Company held 3,077 shares of Colgate-Palmolive worth $282K as of Q2 2026.
  • O'Rourke & Company sold 157 Colgate-Palmolive shares in Q2 2026, an estimated $13.7K.
  • Colgate-Palmolive made up 0.1% of O'Rourke & Company's portfolio in Q2 2026, its #144 holding.
  • O'Rourke & Company first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • O'Rourke & Company's Colgate-Palmolive position peaked at $426K in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on O'Rourke & Company's 13F filing for Q2 2026, filed 14 Aug 2026.